Edwards Lifesciences (EW) Retained Earnings (2009 - 2026)

Edwards Lifesciences has reported Retained Earnings for 18 years, with the latest figure at $14.9 billion in Q2 2026.

• On a quarterly basis, Retained Earnings rose 7.25% year-over-year to $14.9 billion in Q2 2026; TTM through Jun 2026 was $14.9 billion, a 7.25% increase from a year earlier, with the FY2025 full-year figure at $14.2 billion, up 8.15% from the prior year.
• Retained Earnings was $14.9 billion for Q2 2026 at Edwards Lifesciences, up from $14.6 billion in the prior quarter.
• The five-year high for Retained Earnings was $14.9 billion in Q2 2026, with the low at $6.4 billion in Q1 2022.
• Average Retained Earnings over 5 years is $10.7 billion, with a median of $9.5 billion recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Retained Earnings surged 48.23% in 2024, then gained 7.25% in 2026.
• Over 5 years, Retained Earnings stood at $7.6 billion in 2022, then rose by 18.48% to $9.0 billion in 2023, then surged by 46.42% to $13.2 billion in 2024, then grew by 8.15% to $14.2 billion in 2025, then advanced by 4.37% to $14.9 billion in 2026.
• The last three Retained Earnings figures came in at $14.9 billion (Q2 2026), $14.6 billion (Q1 2026), and $14.2 billion (Q4 2025), per Business Quant data.